271 related articles for article (PubMed ID: 28669104)
21. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
24. A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Matsuda T
Jpn J Clin Oncol; 2015 Dec; 45(12):1162-7. PubMed ID: 26423342
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
[TBL] [Abstract][Full Text] [Related]
26. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
29. The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy.
Liu J; Dai Y; Zhou F; Long Z; Li Y; Liu B; Xie D; Tang J; Tan J; Yao K; Zhang Y; Tang Y; He L
Urol Oncol; 2016 Nov; 34(11):484.e1-484.e8. PubMed ID: 27341738
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.
Schmid SC; Zahel T; Haller B; Horn T; Metzger I; Holzapfel K; Seitz AK; Gschwend JE; Retz M; Maurer T
World J Urol; 2016 Apr; 34(4):569-76. PubMed ID: 26260193
[TBL] [Abstract][Full Text] [Related]
31. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
[TBL] [Abstract][Full Text] [Related]
32. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
33. Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
Takenaka Y; Takemoto N; Yasui T; Yamamoto Y; Uno A; Miyabe H; Ashida N; Shimizu K; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
PLoS One; 2016; 11(10):e0164057. PubMed ID: 27732629
[TBL] [Abstract][Full Text] [Related]
34. De-Ritis Ratio Is Associated with Mortality after Cardiac Arrest.
Lu Z; Ma G; Chen L
Dis Markers; 2020; 2020():8826318. PubMed ID: 33204363
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of De Ritis ratio with aspartate aminotransferase and alanine aminotransferase within the reference range.
Ndrepepa G; Holdenrieder S; Kastrati A
Clin Chim Acta; 2023 Jan; 538():46-52. PubMed ID: 36370837
[TBL] [Abstract][Full Text] [Related]
36. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
[TBL] [Abstract][Full Text] [Related]
37. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
[TBL] [Abstract][Full Text] [Related]
38. De Ritis ratio as a predictor of 1-year mortality after burn surgery.
Yu J; Kim HY; Kong YG; Park JH; Seo YJ; Kim YK
Burns; 2021 Dec; 47(8):1865-1872. PubMed ID: 33832798
[TBL] [Abstract][Full Text] [Related]
39. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
[TBL] [Abstract][Full Text] [Related]
40. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
